NCT07017322 Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating Disorders
| NCT ID | NCT07017322 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rogers Behavioral Health |
| Condition | Eating Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-06-03 |
| Primary Completion | 2027-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-06-03 with a primary completion date of 2027-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is to evaluate the feasibility of using a non-invasive brain stimulation device in a sample of inpatients with eating disorders (ED). The study will help researchers evaluate whether their device protocol is practical for eating disorder inpatients as a way to manage eating disorder and anxiety symptoms. A secondary aim of the study is to evaluate preliminary effectiveness of the protocol for reducing pre-meal anxiety during the treatment, and explore effects on eating disorder symptoms over the course of the inpatient admission.
Eligibility Criteria
Inclusion Criteria: 1. Age 18-30 years old at the time of enrollment 2. Enrolled in Rogers Behavioral Health Eating Disorder Recovery Program Inpatient Unit at the Oconomowoc, WI clinic location 3. Have a primary diagnosis of any DSM-5 eating disorder (anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder, other specified feeding or eating disorder) 4. Ability to communicate effectively using written and spoken English 5. Participant is eligible for mealtime anxiety support based on: * ≤ 75% meal plan compliance * Visible anxiety/distress during program meals * Engagement in compensatory behaviors or self-harm before, during, or after meals, or medical staff judge patient to be at risk of same Exclusion Criteria: 1. Metal in the body of any kind (e.g., braces, pacemakers, metal plates or screws, intracranial electrodes, implanted devices/defibrillators, prostheses) 2. Currently taking medication that reduces seizure threshold (e.g., clomipramine) 3. Cranial pathologies (e.g., holes, plates) 4. History of seizure or black-out concussion 5. Pregnancy 6. Risk of suicide/self-harm by self-strangulation with cranial electrotherapy stimulation (CES) device judged by study medical staff 7. Participant calibrates to a stimulation level below 200 microampere (μA)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07017322 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07017322 currently recruiting?
Yes, NCT07017322 is actively recruiting participants. Contact the research team at hana.zickgraf@rogersbh.org for enrollment information.
Where is the NCT07017322 trial being conducted?
This trial is being conducted at Oconomowoc, United States.
Who is sponsoring the NCT07017322 clinical trial?
NCT07017322 is sponsored by Rogers Behavioral Health. The trial plans to enroll 30 participants.